Click here to watch the full presentation!
As we grow and continuously develop our organization dedicated to ophthalmic cell and gene therapies, we strive to engage in key industry discussions and raise awareness of Santen Cell & Gene’s commitment to unlocking the power of cell and gene therapies to restore vision and transform lives. On 31 August 2022, Marianthi Psaha (Global Head, Cell & Gene Business Segment), delivered a presentation at Ophthalmology Futures Retina Forum, where she gave more details about our aspiration to change patient lives, and highlighted how expansion into the cell and gene therapy field fits into our corporate vision, Santen 2030.
“Through our continuous commitment and by developing our organization dedicated to ophthalmic cell and gene therapies, we aim to transform the lives of patients suffering from seriously disabling conditions by accelerating the development and delivery of innovative therapies targeting high unmet medical needs.”
Global Head, Cell & Gene Business Segment